Acadia Healthcare Company, Inc. (ACHC) is a publicly traded Healthcare sector company. As of October 3, 2026, ACHC trades at $28.06 with a market cap of $2.51B and a P/E ratio of -2.23. ACHC moved +4.25% today. Year to date, ACHC is +96.36%; over the trailing twelve months it is +5.41%. Its 52-week range spans $11.43 to $43.26. Analyst consensus is buy with an average price target of $35.10. Rallies surfaces ACHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACHC recently traded at $28.06. Market cap is $2.51B. P/E ratio is -2.23. Revenue is $3.37B.
| Metric | Value |
|---|---|
| Price | $28.06 |
| Market Cap | $2.51B |
| P/E Ratio | -2.23 |
| EPS | $-12.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.26 |
| 52-Week Low | $11.43 |
| Volume | 1.21M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.37B |
| Net Income | $-1.12B |
| Gross Margin | 0.00% |
11 analysts cover ACHC: 0 strong buy, 6 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $35.10.